Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: Results from a randomized clinical trial
2011 ◽
Vol 123
(3)
◽
pp. 505-510
◽
Keyword(s):
2011 ◽
Vol 11
(3-4)
◽
pp. 134-144
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 78
(12)
◽
pp. 2153.e1-2153.e9
Keyword(s):
Keyword(s):